Bio-Path Holdings, Inc.
OTC: BPTH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Vikram Paul Grover
- Employees
- 10
- Headquarters
- Bellaire, United States
- IPO year
- 2008
- Market cap
- $327.0K
- Website
- https://www.biopathholdings.com
Loading BPTH…
Loading profile data…Frequently asked questions about BPTH
What does Bio-Path Holdings, Inc. (BPTH) do?
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonu...
Where does BPTH trade?
Bio-Path Holdings, Inc. (BPTH) trades on the Other OTC.
What sector is BPTH in?
Bio-Path Holdings, Inc. (BPTH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Bio-Path Holdings, Inc.?
Vikram Paul Grover is the chief executive officer of Bio-Path Holdings, Inc. (BPTH).
Where is Bio-Path Holdings, Inc. headquartered?
Bio-Path Holdings, Inc. is headquartered in United States.
Does BPTH pay a dividend?
Bio-Path Holdings, Inc. (BPTH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BPTH go public?
Bio-Path Holdings, Inc. (BPTH) completed its initial public offering in 2008.